Rayonier Inc
SWB:RA6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rayonier Inc
SWB:RA6
|
US |
|
B
|
BioLine RX Ltd
SWB:YP2A
|
IL |
|
ADMA Biologics Inc
NASDAQ:ADMA
|
US |
|
J
|
Jentayu Sustainables Bhd
KLSE:JSB
|
MY |
|
S
|
Spirax-Sarco Engineering PLC
SWB:1LNB
|
UK |
Wall St Price Targets
RA6 Price Targets Summary
Rayonier Inc
According to Wall Street analysts, the average 1-year price target for RA6 is 22.97 EUR with a low forecast of 19.24 EUR and a high forecast of 29.1 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RA6's stock price target?
Price Target
22.97
EUR
According to Wall Street analysts, the average 1-year price target for RA6 is 22.97 EUR with a low forecast of 19.24 EUR and a high forecast of 29.1 EUR.
What is the Revenue forecast for Rayonier Inc?
Projected CAGR
51%
Over the last 14 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 3 years is 51%.
What is the Gross Profit forecast for Rayonier Inc?
Projected CAGR
68%
Over the last 14 years, the compound annual growth rate for Gross Profit has been -7%. The projected CAGR for the next 3 years is 68%.
What is the Operating Income forecast for Rayonier Inc?
Projected CAGR
45%
Over the last 14 years, the compound annual growth rate for Operating Income has been -9%. The projected CAGR for the next 3 years is 45%.
What is the Pre-Tax Income forecast for Rayonier Inc?
Projected CAGR
45%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -10%. The projected CAGR for the next 3 years is 45%.
What is the Net Income forecast for Rayonier Inc?
Projected CAGR
-22%
Over the last 14 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is -22%.
